Article PDF
Avoid common mistakes on your manuscript.
References
Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720–3.
Ashbaugh DG, Bigelow DB, Petty TI, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319–23.
Radermacher P, Santak B, Wust HJ, Tarnow J, Falke KJ. Prostacyclin for the treatment of pulmonary hypertension in the Adult Respiratory Distress Syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 1990; 72: 238–44.
Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, El Torky M, Leeper KV Jr. Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 1991; 100: 943–52.
Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988; 138: 62–8.
ACCP/ SCCM Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864–74.
Artigas A, Carlet J, Le Gall JR, Chastang CL, Blanch L, Fernandez R. Clinical presentation, prognostic factors and outcome of ARDS in the European Collaborative Study (1985-1987). A preliminary report.In: Zapol WM, Lamaire F (Eds.). Adult Respiratory Distress Syndrome, New York: Marcel Dekker Inc., 1991: 37.
Ezri T, Szmuk P, Porta I, Schattner A, Shklar B, Soroker D. Adult Respiratory Distress Syndrome after radical neck dissection — an uncommon complication. Can J Anaesth 1993; 40: 658–63.
Hyers TM. Adult Respiratory Distress Syndrome: definitions, risk factors, and outcome.In: Zapol WM, Lamaire F (Eds.). Adult Respiratory Distress Syndrome, New York: Marcel Dekker Inc., 1991: 23.
Neuhof H. Actions and interactions of mediator systems and mediators in the pathogenesis of ARDS and multiorgan failure. Acta Anaesthesiol Scand Suppl 1991; 95: 7–14.
Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269: 1829–35.
Standiford TJ, Strieter RM. TNF and IL-1 in sepsis; good cytokines gone bad (Editorial). J Lab Clin Med 1992; 120: 179–80.
Bone RC, Balk R, Slotman G, et al. Adult Respiratory Distress Syndrome. Sequence and importance of development of multiple organ failure. The Prostaglandin E1 Study Group. Chest 1992; 101: 320–6.
Gragory GA. Surfactant replacement for respiratory failure: lessons from the neonate. Anesth Analg 1993; 76: 465–6.
Battafarano RJ, Dunn DL. Role of nitric oxide during sepsis (Editorial). Crit Care Med 1992; 20: 1504–5.
Pearl RG. Inhaled nitric oxide. The past, the present, and the future. Anesthesiology 1993; 78: 413–6.
Goodman C. It’s time to rethink health care technology assessment. Int J Technol Assess Health Care 1992; 8: 335–54.
St. John RC, Dorinsky PM. Immunologic therapy for ARDS, septic shock and multiple-organ failure. Chest 1993; 103: 932–43.
Bone RC. Monoclonal antibodies to tumor necrosis factor in sepsis: help or harm? Crit Care Med 1993; 21: 311–2.
Tanio CP, Feldman HI. The HA-1A monoclonal antibody for gram-negative sepsis (Letter). N Engl J Med 1991; 325: 280.
Taylor D. Centoxin — birth of a budget buster. BMJ 1991; 302: 1229.
Schmidt GA. The HA-1A monoclonal antibody for gramnegative sepsis (Letter). N Engl J Med 1991; 325(4): 280–1.
Byrick RJ, Sibbald WJ, Inman KJ,et al. Estimating the financial impact of anti-endotoxin monoclonal antibody therapy in Ontario. (In preparation)
Schulman KA, Glick HA, Rubin H, Eisenberg JM. Costeffectiveness of HA-1A monoclonal antibody for gramnegative sepsis. Economic assessment of a new therapeutic agent. JAMA 1991; 266: 3466–71.
Technology Subcommittee of the Working Group on Critical Care Ontario Ministry of Health. The assessment of technology in Ontario’s critical care system. Can Med Assoc J 1991; 144: 1613–5.
Gattinoni L, Pesenti A, Mascheroni D, et al. Lowfrequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 1986; 256: 881–6.
Conrad SA, Eggerstedt JM, Morris VF, Romero MD. Prolonged intracorporeal support of gas exchange with an intravenacaval oxygenator. Chest 1993; 103: 158–61.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McLean, J.S., Byrick, R.J. ARDS and sepsis — definitions and new therapy. Can J Anaesth 40, 585–590 (1993). https://doi.org/10.1007/BF03009692
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03009692